Twist Bioscience refutes Scorpion Capital short-seller report as misleading; Q4 results Nov 18

Twist Bioscience Corp

Twist calls Scorpion Capital report 'highly misleading' with many distortions and inaccuracies.
Reaffirms commitment to truthful communication, ESG practices, and shipping from Factory of the Future in Jan 2023.
Will report fiscal Q4 and full-year 2022 results on Nov 18, 2022 before market open; conference call at 8am ET.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.